Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
5.16 | 14745880 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.05 | 20464547 20127859 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.84 | 6695378 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.90 | 15955085 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.56 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.28 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.33 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.43 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.84 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.98 | 16206674 16197459 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.87 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.87 | 17049068 20005174 19084267 18984771 19410462 17242785 19487384 19289846 21138602 18821012 15668708 18997820 16873071 19066611 17440819 11161223 17893378 19155303 18351453 20065188 19221464 19103187 18855134 21152245 19115204 16818667 19011961 19244106 16202921 18425577 20544844 16273361 19189212 20390343 19189210 20135344 19142967 19288272 15565566 20859285 18815881 17261762 19059307 18629630 19200415 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.87 | 16443354 16873071 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
5.13 | 16813970 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.99 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.77 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
4.86 | 12619106 12907637 21507988 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
4.86 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
4.86 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.84 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.84 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.96 | 17572228 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.28 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.76 | 12371664 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
5.13 | 16129372 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.17 | 19486331 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.77 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.79 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
4.19 | 17035595 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.83 | 16925845 9211117 10589399 9142499 8800419 9224671 17551590 14991402 9125849 9664655 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.85 | 19031437 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.80 | 19279558 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
5.08 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
3.98 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
8.17 | 16202921 19155303 20544844 17893378 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
8.17 | 16569247 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.07 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.84 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.97 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
8.97 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.43 | 16709447 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
5.07 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.72 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
10.35 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
10.35 | 17994277 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.76 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.22 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.41 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.77 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
7.20 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
7.20 | 9664655 14991402 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.96 | 15720958 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.50 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
5.05 | 16778211 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.20 | 10903974 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
2.51 | 19457130 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.25 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.27 | 17551590 15992940 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.05 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.52 | 8314463 18776723 10903974 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
8.33 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
8.33 | 18625569 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.92 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
4.07 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.12 | 16294345 17596541 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.37 | 17712046 16140955 17649720 12679006 19642359 16331271 19035177 17368321 17294898 16766008 16823087 15748426 17339181 9834237 16788101 17506722 17107899 17217047 19075265 19029980 16935935 17301526 19225113 17361223 16891316 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.55 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.40 | 17567588 15342952 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.57 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.57 | 18397230 16248980 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
8.10 | 2125692 15890375 18177683 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
8.10 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
8.10 | 16684651 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
2.94 | 8603461 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
3.60 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.60 | 20464547 17053015 18569708 18520028 20135361 20869020 18816296 20064080 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
3.60 | 18625569 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.30 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.83 | 11731420 19196722 14580682 16827153 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
5.16 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.90 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.44 | 19393235 12393984 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.44 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.72 | 15990972 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.91 | 16940565 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.40 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.46 | 16381670 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.26 | 17596541 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.66 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.60 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.50 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.50 | 16946489 16594593 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.61 | 19189210 19200415 19196722 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.05 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.61 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
4.22 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.27 | 9142499 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.43 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.20 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.56 | 15976015 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.55 | 12371664 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.06 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.06 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
4.01 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.32 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.33 | 16723453 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.50 | 16283617 16116481 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
6.16 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
6.16 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.90 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.58 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.41 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.41 | 17261132 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.29 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
4.14 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.43 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.38 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
5.38 | 8653321 16712894 17572228 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
4.02 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
5.22 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.59 | 1336536 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.50 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.29 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.05 | 17120751 |